TransDigm price target raised to $1,267 from $1,158 at Truist

Truist raised the firm’s price target on TransDigm to $1,267 from $1,158 and keeps a Buy rating on the shares. The company’s results exceeded expectations, while the management raised its outlook for revenue and EBITDA while lowering its EPS view due to higher interest expense, the analyst tells investors in a research note.